Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : STR-V-53
Catalog No.: PC-22104Not For Human Use, Lab Use Only.
STR-V-53 is a novel glycosylated, liver cancer-selective histone deacetylase (HDAC) inhibitor with IC50 of 24.3/60.1/213.43 nM for HDAC1/2/3/6, demonstrates exquisite selective cytotoxicity against human HCC cells.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
STR-V-53 is a novel glycosylated, liver cancer-selective histone deacetylase (HDAC) inhibitor with IC50 of 24.3/60.1/213.43 nM for HDAC1/2/3/6, demonstrates exquisite selective cytotoxicity against human HCC cells.
STR-V-53 exhibits anti-proliferation effect against Hep-G2 and Huh7 cells with IC50 of 10.4 and 6.25 uM respectively, but lack of
growth inhibition effect against other cancer cells in the NCI-60 panel.
STR-V-53 shows weak inhibition of HDAC 8 and no inhibition of HDAC 11 at the maximum tested concentration of 10 uM.
STR-V-53 is uptaked by GLUT-2 and blockage of GLUT-2 attenuates the cytotoxicity of STR-V-53 against Hep-G2 HCC
cells.
STR-V-53 upregulates PD-L1 and downregulates PD-1 expression, upregulates CD54 (ICAM-1) in HCC cells.
STR-V-53 selectively induces apoptosis in HCC cells, causes cell cycle arrest at the S stage.
STR-V-53 (25, 50 mg/kg, i.p.) effectively suppresses HCC growth in xenograft and murine models of HCC.
STR-V-53 reprogrammed the T cell responses and prolonged median overall survival in an orthotopic HCC model in immunocompetent mice, when combined with anti-PD1 therapy.
| M.Wt | 466.49 | |
| Formula | C21H30N4O8 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Bocheng Wu, et al. bioRxiv. 2024 Mar 28:2024.03.27.587062.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
